FOLLOW US

  • facebook
  • twitter
Fri

March 20, 2026

uBiome founders face fraud charges

America December 18, 2020

Biogen to pay $22M to settle lawsuit over kickback scheme involving its multiple sclerosis drugs

Biogen Inc (NASDAQ: BIIB) agreed to pay $22 million to settle a lawsuit alleging it committed unlawful conduct involving its…

By Marivic Cabural Summers

biogen building

Business March 21, 2019

Biogen (BIIB) Shares Tank 29 Percent after Company Ends Alzheimer’s Drug Trials

The stock price of Biogen (NASDAQ: BIIB) suffered a steep decline after the biotechnology company announced its decision to stop…

By Cedric Dent

Signup for the USA Herald
exclusive Newsletter